Loxo Oncology

Poseida Therapeutics, a member of the Roche Group, is at the forefront of innovation in cell and gene therapies, focusing on developing bold solutions to transform treatment paradigms for life-threatening cancers and genetic diseases. The company's advanced genetic engineering technologies, including a non-viral piggyBac DNA Delivery System and Cas-CLOVER Site-Specific Gene Editing System, offer promising new hope for patients through precise and effective treatments. By targeting specific cell populations, Poseida Therapeutics aims to enhance allogeneic CAR-T therapies and seek functional cures for rare genetic diseases. Their commitment to advancing these pioneering technologies positions them as a leader in the ongoing evolution of therapeutic strategies in the medical field. Generated from the website

Zentalis Pharmaceuticals is a San Diego-based biotech company focused on the discovery and development of clinically differentiated small molecules that target fundamental biological pathways of cancer. Their advanced Integrated Discovery Engine aims to efficiently identify and develop novel oncology therapies to improve the lives of patients affected by cancer. The company is committed to innovation in oncology and aligns with a diverse range of partners and collaborators. Zentalis Pharmaceuticals actively engages in clinical trials, leveraging a dedicated management team and scientific advisory board to guide its strategic initiatives in cancer therapy development. Generated from the website

Pfenex Biopharm Aceuticals is a biotechnology company based in San Diego, CA, specializing in the development and production of innovative biopharmaceuticals. With a focus on cutting-edge research and technology, the company is dedicated to advancing healthcare through the creation of high-quality, cost-effective therapeutic products. Generated from their business information